Gene · 51062
Papers2,411
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,411
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-derived acetylcholine promotes immune evasion in hepatocellular carcinoma by protecting regulatory T cells from ferroptosis. | Int Immunopharmacol | 2026 | 42822277 | PubTator, text mining | PubMed |
| Neutrophil-Driven Inflammation in Pediatric Chronic Recurrent Multifocal Osteomyelitis. | Arthritis Rheumatol | 2026 | 42806909 | PubTator, text mining | PubMed |
| Spatial Association Between Polyamine Metabolism and Lipid Peroxidation in Different Pathological Regions of Glioblastoma. | Biomedicines | 2026 | 42792811 | PubTator, text mining | PubMed |
| Targeting SQLE-Mediated Cholesterol Metabolism to Promote Oxidative Stress and Attenuate Drug Resistance in Osteosarcoma. | Antioxidants (Basel) | 2026 | 42792161 | PubTator, text mining | PubMed |
| Pharmacological targeting of ferroptosis in cancer: mechanisms, tumor immunity, and translational challenges. | Pharmacol Rep | 2026 | 42789241 | PubTator, text mining | PubMed |
| Serum levels of immunoglobulins, tumour markers, and chemokines in gastric cancer patients treated with SOX regimen versus oxaliplatin monotherapy. | J Med Biochem | 2026 | 42780944 | PubTator, text mining | PubMed |
| Ferroptosis in Neurodegenerative Diseases: Iron Dysregulation, GPX4/FSP1 Signaling, and Emerging Neuroprotective Strategies. | Curr Neurovasc Res | 2026 | 42770359 | PubTator, text mining | PubMed |
| Programmed cell death evasion in BRAF V600E-driven primary CNS tumors and thyroid cancer brain metastases. | Front Neurol | 2026 | 42769885 | PubTator, text mining | PubMed |
| Decreased FSP1 expression under chronic hypoxia sensitizes human macrophages towards ferroptosis. | Redox Biol | 2026 | 42759111 | PubTator, text mining | PubMed |
| RNA m6A modification-regulated ferroptosis in cancer: mechanism and therapeutic potential. | Front Cell Dev Biol | 2026 | 42755876 | PubTator, text mining | PubMed |
| High-Throughput Characterization of Human Fibroblast Responses to a Panel of Staphylococcus aureus Antigen Proteins Using Olink Proteomics. | Open Forum Infect Dis | 2026 | 42751267 | PubTator, text mining | PubMed |
| Dual role of ferroptosis in embryonic development, cascade amplification regulatory mechanism and targeted intervention. | Front Cell Dev Biol | 2026 | 42750845 | PubTator, text mining | PubMed |
| Ferroptosis in Low-Density Neutrophils of Tuberculosis Patients Suppresses Bactericidal Function. | Clin Exp Pharmacol Physiol | 2026 | 42725380 | PubTator, text mining | PubMed |
| The research landscape of ferroptosis in ischemic stroke: a bibliometric analysis of the literature from 2017 to 2025 based on the WOS and PubMed databases. | Front Cell Neurosci | 2026 | 42719580 | PubTator, text mining | PubMed |
| Harnessing copper-iron crosstalk: A novel strategy to combat hepatocellular carcinoma. | Med Oncol | 2026 | 42709356 | PubTator, text mining | PubMed |
| AI-enhanced adaptive virtual screening of large libraries for ligand discovery. | Nat Biotechnol | 2026 | 42680826 | PubTator, text mining | PubMed |
| Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC. | Cell Rep Med | 2026 | 42673947 | PubTator, text mining | PubMed |
| Engineered exosomes with RNA-motif short hairpin RNA loading and Rab4-boosted production enable controlled ferroptosis in endometrial carcinoma. | Bioeng Transl Med | 2026 | 42666679 | PubTator, text mining | PubMed |
| TFPT Abundance Is Associated with Growth-Related Phenotypes and Cellular Features Linked to Lipid Peroxidation Defense in Hepatocellular Carcinoma. | Biology (Basel) | 2026 | 42651700 | PubTator, text mining | PubMed |
| Targeting Metal-Dependent Cell Death in Cancer: From Molecular Circuitry to Biomarker-Guided Precision Combination Therapy. | Curr Cancer Drug Targets | 2026 | 42634173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51062/papers